Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 11Phase NA 9Phase 1/2 9Phase 3 5Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 105Unknown 65Recruiting 34Terminated 15Active not recruiting 15Not yet recruiting 9Withdrawn 5

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 25Neoplasms 19Prostatic Neoplasms 15Carcinoma, Non-Small-Cell Lung 15Carcinoma, Hepatocellular 10Urinary Bladder Neoplasms 8Ovarian Neoplasms 8Head and Neck Neoplasms 8Pain 7Lung Neoplasms 7Leukemia, Myeloid, Acute 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Lymphoma, Follicular 6Leukemia 6Uterine Cervical Neoplasms 5Stomach Neoplasms 5Recurrence 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Non-Muscle Invasive Bladder Neoplasms 5Brain Neoplasms 5Small Cell Lung Carcinoma 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma 4Leiomyoma 4Carcinoma 4Urologic Neoplasms 3Urogenital Neoplasms 3Papillomavirus Infections 3

Interventions

Capecitabine 2pembrolizumab 1XELOX 1S 1 (combination) 1Oxaliplatin 1Gastroenterostomy 1Gastric Bypass 1Fluorouracil 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Withdrawn × Stomach Neoplasms × Clear all
NCT02519140 2023-12-04

Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections

Maimonides Medical Center

Phase 3 Withdrawn
Gastrointestinal

Colonic Neoplasms, Stomach Neoplasms

NCT04859582 2021-12-16

KEYNOTE-859

Merck Sharp & Dohme LLC

Phase 3 Withdrawn
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT01470742 2019-12-30

Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer

Samsung Medical Center

Phase 3 Withdrawn
Gastrointestinal

Stomach Neoplasms

NCT02736552 2019-05-08

Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.

Fudan University

Phase 3 Withdrawn
Gastrointestinal

Stomach Neoplasms

NCT00622804 2009-08-03

Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy

The Catholic University of Korea

Phase 3 Withdrawn
90 enrolled
Gastrointestinal

Postgastrectomy Syndromes, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡